Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.

Ferdinando D'AmicoFernando GomollónGiorgos BamiasFernando MagroLaura TargownikClaudia LeitnerTobias Heatta-SpeicherNaiara MichelenaStefanie KoltererJennifer LapthornLaura KauffmanAxel Dignassnull null

Published in: United European gastroenterology journal (2024)

The high percentage of SDC in this global, real-world cohort suggests a large disease burden and high unmet medical need in IBD patients. Future analysis should focus on monitoring and responding to SDC in this cohort and on patients' QoL.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
clinical practice
healthcare
prognostic factors
current status
ulcerative colitis